CClinicalTrials.gg
CompletedNCT03114436CanadaDONATEUpdated May 23, 2019

National Observational Study of Clinical Practices in Deceased Organ Donation

An observational study in Deceased Organ Donation, Critical Illness and Transplantation, sponsored by McMaster University. Completed at 29 sites in Canada. Per ClinicalTrials.gov, last updated 2019-05-23.

Sponsored by McMaster University · Observational

Study type
Observational
Model
Cohort
Time perspective
Prospective
Enrollment
622
Sex
All
01

Study summary

This is a 1-year national prospective cohort study that observes the medical management of consented deceased organ donors at hospitals across Canada with a high volume of deceased donation.

Read the detailed description

This prospective cohort study enrols consecutive adult deceased organ donors with a waiver of research consent and collects various data related to deceased donor care in the ICU from the time of consent for donation to the time of organ recovery. Clinical data includes donor characteristics, type of donation (after neurological death or cardiocirculatory death), resuscitation methods, cardiopulmonary monitoring techniques, medications, blood work, mechanical ventilation, diagnostic imaging, complications, and methods of death declaration. Various clinical data on deceased donors are collected prospectively from the time of consent for organ donation up to and including the day of organ recovery.

The Canada-DONATE study is designed to develop a national platform for future clinical trials in deceased donor care. The main objectives include:

  1. Establish specialized organ donation research teams at participating ICUs.
  2. Observe, record, and describe ICU practices in deceased donor care (e.g., donor resuscitation, organ suitability assessments, death declaration) which are likely to vary by site, region and province and will be very important to inform clinical care protocols for future RCTs.
  3. Engage and work with ODOs from each province to foster data sharing and develop procedures to enhance efficiency in future RCTs.
  4. Investigate the comparative effectiveness of various ICU interventions in deceased donor care to improve the conversion of consented donors to actual donors and to improve the number of transplants per donor.
  5. Produce specific knowledge translation tools that will serve in the future as clinical tools to enhance ICU care and research tools to facilitate RCTs.
02

Conditions studied

  • Deceased Organ Donation
  • Critical Illness
  • Transplantation
03

In context

Critical Illness

1,881 studies on the registry are indexed under Critical Illness; 462 are open to participants now.

This study's enrollment of 622 is above the median of 130 across 867 observational studies indexed under Critical Illness.

Browse Critical Illness studies →

Lead sponsor

McMaster University is the lead sponsor of 720 studies on the registry; 124 are open to participants now.

Of its 6 completed or terminated interventional studies of FDA-regulated products, 2 (33%) have results posted.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
Child (0–17), Adult (18–64), Older adult (65+)
Sexes eligible
All
Accepts healthy volunteers
No
Sampling method
Non-probability sample

Study population

All patients for whom consent for deceased organ donation has been obtained.

Inclusion criteria

  • Admitted into a critical care area (ICU, CCU, ER)
  • Consent has been obtained for Organ Donation

Exclusion criteria

Exclusion Criteria:

  • Admitted into a paediatric critical care area (NICU, PICU)
05

Study design

Observational model
Cohort
Time perspective
Prospective
Enrollment
622 participants (actual)
Patient registry
No

Groups and cohorts

  • Consented deceased organ donors

    Includes neurological determination of death (DND) and by circulatory determination of death (DCD).

    Other: Observational Data Collection

Interventions

  • OtherObservational Data Collection

    All aspects of deceased donor care in the ICU.

06

What researchers measure

Primary outcomes

  1. Adherence to national guidelines for deceased donor care

    For each donor, we will measure adherence to multiple recommendations from national guidelines for the management of deceased organ donors.

    Time frame: Duration of deceased donor care in the ICU (1-5 days per donor).

Secondary outcomes

  1. Organ donation

    This refers to the conversion of a consented organ donor to an actual organ donor.

    Time frame: Duration of deceased donor care in the ICU (1-5 days per donor).

  2. Organ transplantation

    Deceased organ donors can provide up to 8 organ donations each. We will measure the number of transplants that proceed from each consented donor.

    Time frame: Transplantation may occur from 1-5 days from the time of consent.

07

Study locations

29 sites
  • Foothills Medical Centre
    Calgary, Alberta T2N 2T9, Canada
  • Royal Alexandra Hospital
    Edmonton, Alberta T5H 3V9, Canada
  • University of Alberta Hospital
    Edmonton, Alberta T6G 2B7, Canada
  • Royal Columbian Hospital
    New Westminster, British Columbia V3L 3W7, Canada
  • Vancouver General Hospital
    Vancouver, British Columbia V5Z 1M9, Canada
  • St. Paul's Hospital
    Vancouver, British Columbia V6Z 1Y6, Canada
  • Royal Jubilee Hospital
    Victoria, British Columbia V8R 1J8, Canada
  • Victoria General Hospital
    Victoria, British Columbia V8Z 6R5, Canada
  • Hamilton Health Sciences - Hamilton General Hospital
    Hamilton, Ontario L8L 2X2, Canada
  • Hamilton Health Science - Juravinski Hospital
    Hamilton, Ontario L8V 1C3, Canada
  • Kingston General Hospital
    Kingston, Ontario K7L 2V7, Canada
  • London Health Sciences Centre - University Hospital
    London, Ontario N6A 5A5, Canada
  • London Health Sciences Centre - Victoria Hospital
    London, Ontario N6A 5W9, Canada
  • Trillium Health Partners - Trillium Health Centre
    Mississauga, Ontario L5B 1B8, Canada
  • The Ottawa Hospital - Civic Campus
    Ottawa, Ontario K1H 8G7, Canada
  • The Ottawa Hospital - General Hospital
    Ottawa, Ontario K1H 8L6, Canada
  • Sunnybrook Health Sciences Centre
    Toronto, Ontario M4N 3M5, Canada
  • St Michael's Hospital
    Toronto, Ontario M5B 1W8, Canada
  • University Health Network - Toronto General Hospital
    Toronto, Ontario M5G 2C4, Canada
  • University Health Network - Toronto Western Hospital
    Toronto, Ontario M5T 2S8, Canada
  • Hôpital Maisonneuve-Rosemont
    Montreal, Quebec H1T 2M4, Canada
  • Centre hospitalier de l'Université de Montréal - Hôpital Notre-Dame
    Montreal, Quebec H2L 4M1, Canada
  • Centre hospitalier de l'Université de Montréal - Hôtel-Dieu de Montréal
    Montreal, Quebec H2W 1T8, Canada
  • Centre hospitalier de l'Université de Montréal - Hôpital Saint-Luc
    Montreal, Quebec H2X 3J4, Canada
  • Centre Universitaire de Santé McGill/McGill University Health Centre - Hôpital Général de Montreal
    Montreal, Quebec H3G 1A4, Canada
  • Centre Universitaire de Santé McGill/McGill University Health Centre - Hôpital Royal Victoria
    Montreal, Quebec H4A 3J1, Canada
  • Hôpital du Sacré-Cœur de Montréal
    Montreal, Quebec H4J 1C5, Canada
  • Centre Hospitalier Universitaire de Sherbrooke
    Sherbrooke, Quebec J1H 5N4, Canada
  • Centre Hospitalier Universitaire de Québec - Université Laval
    Quebec, G1V 4G2, Canada
08

References and documents

Publications

  • D'Aragon F, Lamontagne F, Cook D, Dhanani S, Keenan S, Chasse M, English S, Burns KEA, Frenette AJ, Ball I, Boyd JG, Masse MH, Breau R, Akhtar A, Kramer A, Rochwerg B, Lauzier F, Kutsogiannis DJ, Ibrahim Q, Hand L, Zhou Q, Meade MO; Canadian Critical Care Trials Group and the Canadian Donation and Transplant Research Program. Variability in deceased donor care in Canada: a report of the Canada-DONATE cohort study. Can J Anaesth. 2020 Aug;67(8):992-1004. doi: 10.1007/s12630-020-01692-7. Epub 2020 May 8. PubMed 32385825 ↗
  • D'Aragon F, Dhanani S, Lamontagne F, Cook DJ, Burns K, Akhtar A, Chasse M, Frenette AJ, Keenan S, Lize JF, Kutsogiannis DJ, Kramer A, Hand LE, Arseneau E, Masse MH, Ribic C, Ball I, Baker A, Boyd G, Rochwerg B, Healey A, Hanna S, Guyatt GH, Meade MO; Canadian Critical Care Trials Group and the Canadian National Transplant Research Program. Canada-DONATE study protocol: a prospective national observational study of the medical management of deceased organ donors. BMJ Open. 2017 Sep 28;7(9):e018858. doi: 10.1136/bmjopen-2017-018858. PubMed 28963316 ↗

Individual participant data

Plan to share: Undecided

09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on May 23, 2019, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT03114436
Lead sponsor
McMaster University
Collaborators
Canadian Critical Care Trials Group, Canadian National Transplant Research Program, Transplant Quebec, Trillium Gift of Life Network, BC Transplant, Southern Alberta Organ Donation Program, Human Organ Procurement and Exchange, Canadian Blood Services, Hamilton Health Sciences Corporation
Responsible party
Maureen O. Meade (Research Program Director, McMaster University) — Principal investigator
First posted
Apr 14, 2017
Start date
Aug 31, 2016
Primary completion
Jul 31, 2018
Completion
Jul 31, 2018
Last update
May 23, 2019

Study contacts

Frederick D'Aragon, MD, MSc
principal investigator · Université de Sherbrooke
Maureen O Meade, MD, MSc
study director · McMaster University

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in May 2019. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion